In August alone, Health Canada granted 4 separate Access to Cannabis for Medical Purposes Regulations (ACMPR) licences, raising the total in the country to 56. Companies making a mark in the industry include: Canopy Growth Corporation (TSX: WEED) (OTC: TWMJF), Aphria Inc. (TSX: APH) (OTC: APHQF), AmeriCann, Inc. (OTC: ACAN), MYM Nutraceuticals Inc. (CSE: MYM) (OTC: MYMMF)
And now the markets too are more than ready for the surge to come.
At one point in time, Canopy Growth Inc. (TSX: WEED) (OTC: TWMJF) was the only cannabis stock access point to invest in, soaring to as high as $13 per share in February of 2017, only to fall more than 40% to under $8 in May of this year.
But even at an over $1.5 billion market cap, Canopy hasn’t put its competitors too far in its dust.
Trailing not too far behind in the great cannabis growth race fellow pot powerhouses Aurora Cannabis (TSXV: ACB) (OTC: ACBFF), and Aphria Inc. (TSXV: APH) (OTC: APHQF) who are each closing in on the $1 billion market cap mark, and a relative newcomer to the race MYM Nutraceuticals Inc. (CSE: MYM) (OTC: MYMMF), which is set to make a major splash in the coming year with one of the world’s largest cannabis greenhouses, that dwarfs anything the country has seen so far.
GROW, BABY, GROW!
While the legal cannabis industry is still very much in its infancy, the sky is the limit on the value this sector can provide.
Beyond the plant’s basic use through straight consumption, whether it’s medicinal or recreational, are several other derivatives that provide major potential for the industry as a whole.
In particular is the Cannabidiol compound of the plant, better known as CBD. Used in all types of therapeutic products from topical ointments to beverages to food products, CBD-only products deliver much of the medicinal benefits of the cannabis plant, without the high that’s typically attributed to cannabis’ other product, THC.
Legal in all 50 US states (as well as in Canada), the American CBD market hit $170 million in 2016, and is projected to hit $1 billion by 2020, while the American marijuana industry as a whole is expected to hit $50 billion by 2026.
In order to get to that milestone, however, growth capabilities are going to need to expand, and quite rapidly.
RISE OF THE MEGA GREENHOUSE
Much like in the construction industry’s competitive race to build ‘megastructures’, so too is there an ongoing race to build the biggest and best greenhouses in the world.
The world’s largest marijuana greenhouse distinction currently goes to Canopy’s Tweed facility in Niagara-on-the-Lake, Ontario, which covers 350,000 square feet of greenhouse space.
However, Canopy’s competitors at Aurora Cannabis began work on their Leduc facility near the Edmonton Airport, which was to be more than double the size, clocking in at 800,000 square feet of growing space. A facility of that size is capable of 100,000 kgs of cannabis annually.
Set to surpass Aurora’s behemoth is AmeriCann Inc. (OTC: ACAN), which announced its plans to build the largest cannabis greenhouse facility in the USA at roughly 1 million square feet, to be located in Massachusetts.
But, like a mega tower that’s set to be the tallest in the world, but is surpassed even in the planning stage by an even greater monolith, along comes MYM.
MYM Nutraceuticals and its majority-owned subsidiary CannCanada signed an exclusive deal with the aptly-named Quebec municipality of Weedon, to build a 1.5 million-square-foot cannabis production facility, consisting of fifteen 100,000-square-foot-greenhouses.
This massive marijuana operation will be one of the largest grow operations on the planet, with the potential to produce over 150,000 kgs of cannabis per year-or roughly $750,000,000 annually.
MYM’S MAJOR MOVE
The project in Weedon is unique to the industry, as it’s the first time a cannabis producer has worked in tandem with a municipality to create jobs and spark an entire industry in the process.
As it is laid out, the plans will have Weedon itself acquiring the 329 acres of land for MYM to construct upon.
The deal was originally signed between the municipality and CannaCanada. MYM went on to acquire 75% of CannaCanada, and is set to earn an additional 15% to take it to 90% ownership upon completion.
Both the architectural and security plans for Phase One of the Weedon project are complete, which will account for the first 300,000 square feet of greenhouse space, with another four phases still in development.
Along with the Weedon facility, MYM has advanced on another Quebec-based project, with the recent approval and permitting to begin construction on the company’s smaller facility in Laval. Phase one of construction for the Lavalfacility is scheduled for completion by the end of Q4 2017, with the capability of producing 1,000 kgs of cannabis annually.
Through integration, MYM is diversified across much of the cannabis sector, from growth, to formulation and production, to branding and distribution.
At this point it has many of the tools in place to leap into that of a major status among the Auroras, Aphrias, and Canopys of the world. While those companies range from $800 million to $1.5 billion in market caps, MYM Nutraceuticals remains undervalued at a roughly $27 million market cap.
MYM’s operations are spread across its assets, ranging from CannaCanada in Weedon, to its other LP subsidiary Sublime in Montreal, to its products and branded entities Joshua Tree, MyHemp Skin Therapy, and HempMed.
Still relatively new to the market, MYM has more than doubled its value since it began trading in March of this year. Acting as an umbrella for several cannabis-related outlets, MYM Nutraceuticals appears to be in line for a promotion to a bigger board in the coming quarters.
Aphria Inc., boasts itself as one of Canada’s lowest cost producers, that produces, supplies and sells medical cannabis. Located in the greenhouse capital of Canada, Leamington, Ontario, Aphria provides pharma-grade medical cannabis, and quality patient care. Aphria was the first public LP to report positive cash flow from operations, and the first to report positive earnings in consecutive quarters.
Through its wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., Aurora Cannabis is a major LP, operating a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta. Aurora made waves when it announced the construction of its 800,000 square foot “Aurora Sky” facility second 800,000 square foot production facility at the Edmonton International Airport. Aurora’s also involved in Quebec, with its third 40,000 square foot production facility set to be completed in Pointe-Claire, Quebec, on Montreal’s West Island. Aurora also holds a minority stake in leading extraction technology company Radient Technologies Inc., based in Edmonton, and a minority stake in Australian company Cann Group Limited, which was the first in Australia to conduct research on and cultivate medical cannabis. Aurora also owns German wholesale importer, exporter, and EU medical cannabis distributor Pedanios.
The granddaddy of the corporate cannabis sector, Canopy Growth is the world’s largest diversified cannabis company. Canopy boasts a wide offering of distinct brands and curated cannabis varieties in dried, oil and capsule forms. Most widely recognized is Canopy’s subsidiary Tweed which is the world’s most recognized marijuana production brand, as well as an industry educator. Accompanying Tweed in Canopy’s portfolio is medical-grade cannabis producers Bedrocan Canada. In total, Canopy Growth’s numerous state-of-the-art production facilities total over half a million square feet of GMP-certified indoor and greenhouse production capacity.
For a more in-depth look into MYM you can view the in-depth report at USA News Group from last week: http://usanewsgroup.com/2017/08/29/invest-in-the-marijuana-stock-boom-2/
By G. Joel Chury
Legal Disclaimer/Disclosure: This piece is an advertorial and has been paid for. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this Report should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. We make no guarantee, representation or warranty and accept no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of USA News Group only and are subject to change without notice. USA News Group assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this Report and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this Report.
DISCLAIMER: USA News Group is Source of all content listed above. FN Media Group, LLC (FNM), is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with USA News Group or any company mentioned herein. The commentary, views and opinions expressed in this release by USA News Group are solely those of USA News Group and are not shared by and do not reflect in any manner the views or opinions of FNM. FNM is not liable for any investment decisions by its readers or subscribers. FNM and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM was not compensated by any public company mentioned herein to disseminate this press release.
FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
U.S. Phone: +1(954)345-0611
SOURCE USA News Group